These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Development of a Risk-stratified Approach for Follow-up Imaging After Percutaneous Thermal Ablation of Sporadic Stage One Renal Cell Carcinoma. Dreyfuss LD; Wells SA; Best SL; Hedican SP; Ziemlewicz TJ; Lubner MG; Hinshaw JL; Lee FT; Nakada SY; Abel EJ Urology; 2019 Dec; 134():148-153. PubMed ID: 31465794 [TBL] [Abstract][Full Text] [Related]
30. Tumor Growth Kinetics and Oncologic Outcomes of Patients Undergoing Active Surveillance for Residual Renal Tumor following Percutaneous Thermal Ablation. Chen JX; Maass D; Guzzo TJ; Bruce Malkowicz S; Wein AJ; Soulen MC; Clark TWI; Nadolski GJ; William Stavropoulos S J Vasc Interv Radiol; 2016 Sep; 27(9):1397-1406. PubMed ID: 27234485 [TBL] [Abstract][Full Text] [Related]
31. Renal Cell Carcinoma: Comparison of RENAL Nephrometry and PADUA Scores with Maximum Tumor Diameter for Prediction of Local Recurrence after Thermal Ablation. Maxwell AWP; Baird GL; Iannuccilli JD; Mayo-Smith WW; Dupuy DE Radiology; 2017 May; 283(2):590-597. PubMed ID: 27875105 [TBL] [Abstract][Full Text] [Related]